Illustration of therapy session

MindLife is taking an active role in developing tools, technologies and processes that are of immediate benefit to primary care providers dealing with mental health and related mind-body conditions in patients.

There is a huge demand for effective solutions in mental health as well as for mind-body diseases (e.g. IBS, fibromyalgia, myalgic encephalomyelitis) that have no effective medication or treatment today. However, resources in the clinical setting are extremely limited: GP surgeries are at full capacity, referrals to secondary care are increasing, yet there are not enough secondary care specialists to answer the demand. Moreover, the treatments available are not effective enough for most mentally ill patients who receive them, e.g. about 60% of people who received treatment for PTSD do not recover.

Many patients receive medications for symptoms (e.g. antidepressants) that do not address the cause of the problem and have negative side effects.

Real-world solutions

MindLife is now creating the next generation of solutions for therapists and patients in collaboration with NHS Trusts, which are being tested and implemented within the NHS. This includes software tools for primary and secondary care practitioners to assess and analyse each patient’s specific state and needs and recommend the most appropriate and effective treatments. We can also analyse the progress of patients, predict the probability of recovery and provide recommendations to both the clinician and patient to improve their outcome.

AiOracle ↗︎

A dynamic new progress feedback system to help therapists and their patients improve treatment outcomes

StratCare ↗︎

An advanced tool, designed to assist psychotherapists to make treatment recommendations based on the latest psychological science and artificial intelligence.

MindLife is also working on real-world solutions to reduce GP workload by giving patients a suite of scientifically-validated interventions to use at home, reducing the need for multiple referrals to secondary care.

We also hope to reduce the current frustration of GP seeing their patients’ continued suffering over their lifetime with chronic conditions without effective tools to help them.